Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

Go back to Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.87 +0.32 (3.03%)
Previous Close $10.55    52 Week High $2.18 
Open $10.80    52 Week Low $0.30 
Day High $10.88    P/E N/A 
Day Low $10.79    EPS $-3.32 
Volume 94,327